Ticker
ANABCompany Name
ANAPTYSBIO INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Invested Capital | Net Income Common Stock | Return on Invested Capital |
---|---|---|---|
6/30/2025 | $ 301.72M | $ -132.59M | -43.95% |
3/31/2025 | $ 379.98M | $ -140.62M | -37.01% |
12/31/2024 | $ 440.33M | $ -145.23M | -32.98% |
9/30/2024 | $ 451.43M | $ -165.66M | -36.7% |
6/30/2024 | $ 388.81M | $ -170.12M | -43.75% |
3/31/2024 | $ 375.35M | $ -163.3M | -43.51% |
12/31/2023 | $ 416.72M | $ -163.62M | -39.26% |
9/30/2023 | $ 449.89M | $ -147.82M | -32.86% |
6/30/2023 | $ 477.18M | $ -144.01M | -30.18% |
3/31/2023 | $ 517.67M | $ -136.72M | -26.41% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Net Inc. Cmn. / Inv. Capital
(=) ROIC
ROIC for ANAPTYSBIO INC is calculated as follows: Net Inc. Cmn. [ $ -73.84M ] / Inv. Capital [ $ 360.24M ]
(=) ROIC [ -20.5% ]
Minimum
Jun 30, 2025
Maximum
Sep 30, 2021
Average
Median
filtered constituents | 3.36K |
---|---|
min | -46.36% |
max | 48.66% |
average | 0.69% |
median | 3.38% |
std | 15.18% |